The use of endovascular therapy (EVT) for lower extremity atherosclerosis is markedly increasing while open surgical bypass is in decline. The results of EVT for critical limb ischaemia (CLI) are difficult to evaluate, especially for patients with diabetes. To date, only one randomized, prospective
Dual antiplatelet therapy in surgery for critical limb ischaemia
โ Scribed by A. Burdess; A. Nimmo; O. J. Garden; J. A. Murie; A. R. Dawson; K. A. A. Fox; D. E. Newby
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 71 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6503
No coin nor oath required. For personal study only.
โฆ Synopsis
VSGBI abstracts 5 (0โข82 [0โข52-1โข46] versus 1โข62 [0โข86-2โข34], p < 0โข001), yet soluble P-selectin was significantly increased (43โข26 [13โข88-86โข7] versus 24โข67 [13โข41-43โข32], p = 0โข039). Stimulated P-selectin was similar in both groups. Markers of coagulation were significantly increased in patients on HD: TAT 4โข59 (2โข67-6โข04) versus 2โข84 (1โข81-3โข82), p < 0โข001 and D-dimer 876โข5 (434โข2-1338โข5) versus 265โข5 (175โข0-401โข51), p < 0โข001.
Conclusion:
Patients on HD have a pro-thrombotic state with chronically activated platelets and elevated markers of coagulation. Drug therapy to counteract this pro-thrombotic state should be considered with the aim of preventing both cardiac events and vascular access thrombosis.
๐ SIMILAR VOLUMES